More than 7 in 10 Americans support access to medication abortion, and even more back the Food and Drug Administration's ability to regulate drugs, a new Axios-Ipsos poll finds.
Why it matters: The findings suggest a Supreme Court decision that would overrule the FDA to limit access to the commonlyused abortion pill mifepristone would be out of step with public sentiment in the post-Roe world.
A surge of dengue cases in North and South America is on track to make 2024 the worst year yet for the mosquito-borne virus as Puerto Rico scrambles to contain an outbreak.
The big picture: The combination of climate change and El Niño are fueling conditions allowing the disease-carrying Aedes aegypti mosquitoto spread earlier than usual and in new areas, according to the World Health Organization.
Enrolling in Medicaid and staying on the program's rolls is about to get easier under a streamlined process the Biden administration finalized on Wednesday.
Why it matters: The changes are expected to increase Medicaid enrollment by about 1.3 million people when fully implemented in 2028.
Even as financial conditions improve at health systems across the U.S., a rash of recent stories about layoffs or unit closures underscore a complex picture for the industry.
Why it matters: High inflation, worsening reimbursement and increasingly fierce competition for outpatient services are challenging the post-COVID rebound hospitals are hoping for as patients seek delayed care.
Former President Trump's recent promise not to cut entitlement programs is notably silent on Medicaid — but GOP ambitions for shrinking the safety-net health care program could risk backlash similar to the party's Obamacare repeal debacle.
Why it matters: Republicans who argue Medicaid has grown far too large are eyeing steep cuts to the program should the party win full control of Washington in November.
